ASX:MYE Metarock Group (MYE) Stock Price, News & Analysis → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free MYE Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume63,281 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield12.50%Price TargetN/A Stock AnalysisStock Analysis Get Metarock Group alerts: Email Address Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... About Metarock Group Stock (ASX:MYE)Metarock Group Limited provides mining, contracting, training, and related services to the underground long wall coal mining operations and industrial products and services in coalfields and supporting industries in Australia. It offers various mining services, which include new mine development, mine operation, training, roadway construction, ventilation, conveyors, longwall relocations, and application of polymeric strata support. The company also provides cable hanging bracket; chemicals products, which include geosorb, quick drive cement, road salt, and safemark paint; conveyor consumables; and dewatering products such as snorebox, strainers, and suction strainer. In addition, it offers droppers and streamers; dusters; mining safety accessories such as cable hanging crook, lifelines, and measuring sticks; nuts and pipe hanging brackets; pogos and snapjacks; props and rollers; shouldered pipe and manifolds; and ventilation, visi-clips, and webbing straps. The company was formerly known as Mastermyne Group Limited and changed its name to Metarock Group Limited in November 2021. Metarock Group Limited was founded in 1996 and is headquartered in Mackay, Australia.Read More Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... MYE Stock News HeadlinesMarch 1, 2023 | au.finance.yahoo.comMetarock Group Limited (MYE.AX)February 21, 2023 | finance.yahoo.comUPDATE 1-Chechnya's Kadyrov: one day I plan my own mercenary groupApril 25, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.February 19, 2023 | finance.yahoo.comInvestors in My Food Bag Group (NZSE:MFB) have unfortunately lost 62% over the last yearSee More Headlines Receive MYE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Metarock Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/19/2019Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorEnergy Industry Thermal Coal Sub-IndustryN/A Current SymbolASX:MYE CUSIPN/A CIKN/A Webwww.mastermyne.com.au Phone61 7 4963 0400FaxN/AEmployees1,338Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.03 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-4.37Net Income$-74,010,000.00 Net Margins0.07% Pretax MarginN/A Return on Equity1.11% Return on Assets4.07% Debt Debt-to-Equity Ratio162.49 Current Ratio0.90 Quick Ratio0.57 Sales & Book Value Annual Sales$491.77 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.00 Book ValueA$0.14 per share Price / BookN/AMiscellaneous Outstanding Shares306,530,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.69 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Jeffrey Keith WhitemanCEO & Managing DirectorMr. James GloverChief Executive Officer of PybarMr. Jonathan RomckeExecutive ChairMr. Andrew David Ritter B.Com.C.A., Company SecretaryKey CompetitorsAustChinaASX:AUHAustralian Pacific CoalASX:AQCBanpu PublicOTCMKTS:BNPJYChina Coal EnergyOTC:CCOZFExxaro ResourcesOTCMKTS:EXXAFView All CompetitorsInsidersAndrew WattsSold 153,095 sharesTotal: $20,055.45 ($0.13/share)Jonathan RomckeSold 4,514,868 sharesTotal: $609,507.18 ($0.14/share)Andrew WattsSold 718,537 sharesTotal: $82,631.76 ($0.12/share)Paul GreenBought 1,264,999 shares on 7/20/2023Total: $164,449.87 ($0.13/share)Paul GreenSold 1,264,999 sharesTotal: $164,449.87 ($0.13/share) MYE Stock Analysis - Frequently Asked Questions How were Metarock Group's earnings last quarter? Metarock Group Limited (ASX:MYE) posted its quarterly earnings data on Tuesday, February, 19th. The company reported $0.03 EPS for the quarter. Metarock Group had a trailing twelve-month return on equity of 1.11% and a net margin of 0.07%. Is Metarock Group a good dividend stock? Metarock Group (ASX:MYE) pays an annual dividend of A$0.05 per share and currently has a dividend yield of 12.50%. MYE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 166.67%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for MYE. This page (ASX:MYE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metarock Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
